{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T11:57:31Z","timestamp":1768478251221,"version":"3.49.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,6,4]],"date-time":"2013-06-04T00:00:00Z","timestamp":1370304000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1186\/1471-2407-13-274","type":"journal-article","created":{"date-parts":[[2013,6,4]],"date-time":"2013-06-04T08:16:07Z","timestamp":1370333767000},"source":"Crossref","is-referenced-by-count":32,"title":["NOTCH1 mutations influence survival in chronic lymphocytic leukemia patients"],"prefix":"10.1186","volume":"13","author":[{"given":"Kerstin","family":"Willander","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ravi Kumar","family":"Dutta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonas","family":"Ungerb\u00e4ck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebeqa","family":"Gunnarsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gunnar","family":"Juliusson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mats","family":"Fredrikson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mats","family":"Linderholm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"S\u00f6derkvist","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,6,4]]},"reference":[{"key":"3908_CR1","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1056\/NEJMra041720","volume":"352","author":"N Chiorazzi","year":"2005","unstructured":"Chiorazzi N, Rai KR, Ferranini M: Chronic lymphocytic leukemia. N Engl J Med. 2005, 352: 805-815.","journal-title":"N Engl J Med"},{"key":"3908_CR2","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1056\/NEJMoa1109016","volume":"365","author":"L Wang","year":"2011","unstructured":"Wang L, Lawrence MS, Wan Y, Stojanov P, Sougnez C, Stevenson K, Werner L, Sivachenko A, DeLuca DS, Zhang L, Zhang W, Zhang W, Vartanov AR, Fernandes SM, Goldstein NR, Folco EG, Cibulskis K, Tesar B, Sievers QL, Shefler E, Gabriel S, Hacohen N, Reed R, Meyerson M, Golub TR, Lander ES, Neuberg D, Brown JR, Getz G, Wu CJ: SF3B1 and other novel cancer genes in chronic lymphocytic leukemia. N Engl J Med. 2011, 365: 2497-2506.","journal-title":"N Engl J Med"},{"key":"3908_CR3","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1182\/blood.V94.6.1840","volume":"94","author":"RN Damle","year":"1999","unstructured":"Damle RN, Wasil T, Fais F, Ghiotto F, Valetto A, Allen SL, Buchbinder A, Budman D, Dittmar K, Kolitz J, Lichtman SM, Schulman P, Vinciguerra VP, Rai KR, Ferrarini M, Chiorazzi N: IgV gene mutation status and CD 38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood. 1999, 94: 1840-1847.","journal-title":"Blood"},{"key":"3908_CR4","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1182\/blood.V94.6.1848","volume":"94","author":"TJ Hamblin","year":"1999","unstructured":"Hamblin TJ, Davis Z, Gardiner A, Oscier DG, Stevenson FK: Unmutated IgV(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood. 1999, 94: 1848-1854.","journal-title":"Blood"},{"key":"3908_CR5","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.1056\/NEJM200012283432602","volume":"343","author":"H D\u00f6hner","year":"2000","unstructured":"D\u00f6hner H, Stielgenbauer S, Benner A, Leupolt E, Kr\u00f6ber A, Bullinger L, D\u00f6hner K, Bentz M, Lichter P: Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med. 2000, 343: 1910-1916.","journal-title":"N Engl J Med"},{"key":"3908_CR6","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1111\/j.1365-2141.2010.08368.x","volume":"151","author":"P Sportoletti","year":"2010","unstructured":"Sportoletti P, Baldoni S, Cavalli L, Del Papa B, Bonifacio E, Ciurnelli R, Bell AS, Di Tommaso A, Rosati E, Crescenzi B, Mecucci C, Screpanti I, Marconi P, Martelli MF, Di Ianni M, Falzetti F: Notch1 PEST domain mutation is an adverse prognostic factor in B-CLL. British Journal of Haematology. 2010, 151: 404-406.","journal-title":"British Journal of Haematology"},{"key":"3908_CR7","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nature10113","volume":"475","author":"XS Puente","year":"2011","unstructured":"Puente XS, Pinyol M, Quesada V, Conde L, Ordonez GR, Villamor N, Escaramis G, Jares P, Be\u00e0 S, Gonz\u00e1lez-D\u00edaz M, Bassaganyas L, Baumann T, Juan M, L\u00f3pez-Guerra M, Colomer D, Tub\u00edo JM, L\u00f3pez C, Navarro A, Tornador C, Aymerich M, Rozman M, Hern\u00e1ndez JM, Puente DA, Freije JM, Velasco G, Guti\u00e9rrez-Fern\u00e1ndez A, Costa D, Carri\u00f3 A, Guijarro S, Enjuanes A: Whole genome sequencing identifies recurrent mutations in chronic lymphocytic leukemia. Nature. 2011, 475: 101-105.","journal-title":"Nature"},{"key":"3908_CR8","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1084\/jem.20110921","volume":"208","author":"G Fabbri","year":"2011","unstructured":"Fabbri G, Rasi S, Rossi D, Trifonov V, Khiabanian H, Ma J, Grunn A, Fangazio M, Capello D, Monti S, Cresta S, Gargiulo E, Forconi F, Guarini A, Arcaini L, Paulli M, Laurenti L, Larocca LM, Marasca R, Gattei V, Oscier D, Bertoni F, Mullighan CG, Fo\u00e1 R, Pasqualucci L, Rabadan R, Dalla-Favera R, Gaidano G: Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation. J Exp Med. 2011, 208: 1389-1401.","journal-title":"J Exp Med"},{"key":"3908_CR9","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1182\/blood-2011-09-379966","volume":"119","author":"D Rossi","year":"2012","unstructured":"Rossi D, Rasi S, Fabbri G, Spina V, Fangazio M, Forconi F, Marasca R, Laurenti L, Bruscaggin A, Cerri M, Monti S, Cresta S, Fam\u00e0 R, De Paoli L, Bulian P, Gattei V, Guarini A, Deaglio S, Capello D, Rabadan R, Pasqualucci L, Dalla-Favera R, Fo\u00e0 R, Gaidano G: Mutations of Notch1 are an independent predictor of survival in chronic lymphocytic leukemia. Blood. 2012, 119: 521-529.","journal-title":"Blood"},{"key":"3908_CR10","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1038\/leu.2011.361","volume":"26","author":"K Shedden","year":"2011","unstructured":"Shedden K, Li Y, Quillette P, Malek SN: Characteristics of chronic lymphocytic leukemia with somatically acquired mutations in exon 34. Leukemia. 2011, 26: 1108-1110.","journal-title":"Leukemia"},{"key":"3908_CR11","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/leu.2012.307","volume":"27","author":"L Mansouri","year":"2013","unstructured":"Mansouri L, Cahill N, Gunnarsson R, Smedby KE, Tj\u00f6nnfjord E, Hjalgrim H, Juliusson G, Geisler C, Rosenquist R: NOTCH1 and SF3B1 mutations can be added to the hierarchical prognostic classification in chronic lymphocytic leukemia. Leukemia. 2013, 27: 512-514.","journal-title":"Leukemia"},{"key":"3908_CR12","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1182\/blood-2008-02-139725","volume":"113","author":"E Rosati","year":"2009","unstructured":"Rosati E, Sabatini R, Rampino G, Tabilio A, Di Ianni M, Fettucciari K, Bartoli A, Coaccioli S, Screpanti I, Marconi P: Constitutively activated Notch signaling is involved in survival and apoptosis resistance of B-CLL cells. Blood. 2009, 113: 856-865.","journal-title":"Blood"},{"key":"3908_CR13","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/ni1045","volume":"5","author":"F Radtke","year":"2004","unstructured":"Radtke F, Wilson A, Mancini SJC, Robson MacDonald H: Notch regulation of lymphocyte development and function. Nature Immunology. 2004, 5: 247-253.","journal-title":"Nature Immunology"},{"key":"3908_CR14","doi-asserted-by":"publisher","first-page":"18261","DOI":"10.1073\/pnas.0606108103","volume":"103","author":"T Palomero","year":"2006","unstructured":"Palomero T, Lim WK, Odom DT, Sulis ML, Real PJ, Margolin A, Barnes KC, O\u2019Neil J, Neuberg D, Weng AP, Aster JC, Sigaux F, Soulier J, Look AT, Young RA, Califano A, Ferrando AA: Notch1 directly regulates c-MYC and activates a feed-forward-loop transcriptional network promoting leukemic cell growth. PNAS. 2006, 103: 18261-18266.","journal-title":"PNAS"},{"key":"3908_CR15","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1111\/j.1349-7006.2009.01130.x","volume":"100","author":"SY Lee","year":"2009","unstructured":"Lee SY, Kumano K, Nakazaki K, Sanada M, Matsumoto A, Yamamoto G, Nannya Y, Suzuki R, Ota S, Ota Y, Izutsu K, Sakata-Yanagimoto M, Hangaishi A, Yagita H, Fukayama M, Seto M, Kurokawa M, Ogawa S, Chiba S: Gain-of-function mutations and copy number increases of Notch2 diffuse large B-cell lymphoma. Cancer Science. 2009, 100: 920-926.","journal-title":"Cancer Science"},{"key":"3908_CR16","doi-asserted-by":"publisher","first-page":"3742","DOI":"10.1182\/blood.V99.10.3742","volume":"99","author":"R Hubmann","year":"2002","unstructured":"Hubmann R, Schwarzmeier JD, Sheta M, Hilgarth M, Duechler M, Dettke M, Berger R: Notch2 is involved in overexperssion of CD23 in B-cell chronic lymphocytic leukemia. Blood. 2002, 99: 3742-3747.","journal-title":"Blood"},{"key":"3908_CR17","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1111\/j.1600-0609.2010.01470.x","volume":"85","author":"K Willander","year":"2010","unstructured":"Willander K, Ungerb\u00e4ck J, Karlsson K, Fredrikson M, S\u00f6derkvist P, Linderholm M: MDM2 SNP309 promoter polymorphism, an independent prognostic factor in chronic lymphocytic leukemia. European Journal of Haematology. 2010, 85: 251-256.","journal-title":"European Journal of Haematology"},{"key":"3908_CR18","doi-asserted-by":"publisher","first-page":"5446","DOI":"10.1182\/blood-2007-06-093906","volume":"111","author":"M Hallek","year":"2008","unstructured":"Hallek M, Cheson BD, Catovsky D, Caligaris-Cappio F, Dighiero G, D\u00f6hner H, Hillmen P, Keating MJ, Montserrat E, Rai KR, Kipps TJ: Guidelines for diagnosis and treatment of chronic lymphocytic leukemia: a report from an international workshop on chronic lymphocytic leukemia updating the national cancer institute working group 1996 guidelines. Blood. 2008, 111: 5446-5456.","journal-title":"Blood"},{"key":"3908_CR19","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1016\/0888-7543(89)90129-8","volume":"5","author":"M Orita","year":"1989","unstructured":"Orita M, Suzuki Y, Sekiya T, Hayashi K: Rapid and sensitive detection of point mutations and DNA polymorphism using the polymerase chain reaction. Genomics. 1989, 5: 874-879.","journal-title":"Genomics"},{"key":"3908_CR20","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1038\/sj.leu.2403202","volume":"17","author":"JJ van Dongen","year":"2003","unstructured":"van Dongen JJ, Langerak AW, Br\u00fcggemann M, Evans PA, Hummel M, Lavender FL, Delabesse E, Davi F, Schuuring E, Garc\u00eda-Sanz R, van Krieken JH, Droese J, Gonz\u00e1lez D, Bastard C, White HE, Spaargaren M, Gonz\u00e1lez M, Parreira A, Smith JL, Morgan GJ, Kneba M, Macintyre EA: Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia. 2003, 17: 2257-2317.","journal-title":"Leukemia"},{"key":"3908_CR21","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1126\/science.1102160","volume":"306","author":"AP Weng","year":"2004","unstructured":"Weng AP, Ferrando AA, Lee W, Morris JP, Silverman LB, Sanchez-Irizarry C, Blacklow SC, Look AT, Aster JC: Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science. 2004, 306: 269-271.","journal-title":"Science"},{"key":"3908_CR22","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1126\/science.1208130","volume":"333","author":"N Stransky","year":"2011","unstructured":"Stransky N, Egloff AM, Tward AD, Kostic AD, Cibulskis K, Sivachenko A, Kryukov GV, Lawrence MS, Sougnez C, McKenna A, Shefler E, Ramos AH, Stojanov P, Carter SL, Voet D, Cort\u00e9s ML, Auclair D, Berger MF, Saksena G, Guiducci C, Onofrio RC, Parkin M, Romkes M, Weissfeld JL, Seethala RR, Wang L, Rangel-Escare\u00f1o C, Fernandez-Lopez JC, Hidalgo-Miranda A, Melendez-Zajgla J: The mutational landscape of head and neck squamous cell carcinoma. Science. 2011, 333: 1157-1160.","journal-title":"Science"},{"key":"3908_CR23","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1084\/jem.20120904","volume":"209","author":"D Rossi","year":"2012","unstructured":"Rossi D, Trifonov V, Fangazio M, Bruscaggin A, Rasi S, Spina V, Monti S, Vaisitti T, Arruga F, Fam\u00e0 R, Ciardullo C, Greco M, Cresta S, Piranda D, Holmes A, Fabbri G, Messina M, Rinaldi A, Wang J, Agostinelli C, Piccaluga PP, Lucioni M, Tabb\u00f2 F, Serra R, Franceschetti S, Deambrogi C, Daniele G, Gattei V, Marasca R: The coding genome of splenic marginal zone lymphoma: activation of NOTCH2 and other pathways regulating marginal zone development. J Exp Med. 2012, 209: 1537-1551.","journal-title":"J Exp Med"},{"key":"3908_CR24","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1084\/jem.20120910","volume":"209","author":"MJ Kiel","year":"2012","unstructured":"Kiel MJ, Velusamy T, Betz BL, Zhao L, Weigelin HG, Chiang MY, Huebner-Chan DR, Bailey NG, Yang DT, Bhagat G, Miranda RN, Bahler DW, Medeiros LJ, Lim MS, Elenitoba-Johnson KS: Whole-genome sequencing identifies recurrent somatic NOTCH2 mutations in splenic marginal zone lymphoma. J Exp Med. 2012, 209: 1553-1565.","journal-title":"J Exp Med"},{"key":"3908_CR25","doi-asserted-by":"publisher","first-page":"3322","DOI":"10.1182\/blood-2008-04-154070","volume":"112","author":"T Zenz","year":"2008","unstructured":"Zenz T, Kr\u00f6ber A, Scherer K, H\u00e4be S, B\u00fchler A, Benner A, Denzel T, Winkler D, Edelmann J, Schw\u00e4nen C, D\u00f6hner H, Stilgenbauer S: Monoallelic TP53 inactivation is associated with poor prognosis in chronic lymphocytic leukemia: results from a detailed genetic characterization with long-term follow-up. Blood. 2008, 112: 3322-3329.","journal-title":"Blood"},{"key":"3908_CR26","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1182\/blood-2011-10-386144","volume":"119","author":"V Baletti","year":"2012","unstructured":"Baletti V, Bottoni A, Palamarchuk A, Alder H, Rassenti LZ, Kipps TJ: Notch1 mutations in CLL associated with trisomy 12. Blood. 2012, 119: 329-331.","journal-title":"Blood"},{"key":"3908_CR27","doi-asserted-by":"publisher","first-page":"437","DOI":"10.3324\/haematol.2011.060129","volume":"97","author":"I Del Guidice","year":"2012","unstructured":"Del Guidice I, Rossi D, Chiaretti S, Marinelli M, Tavolaro S, Gabrielli S, Laurenti L, Marasca R, Rasi S, Fangazio M, Guarini A, Gaidano G, Fo\u00e0 R: Notch1 mutations in +12 chronic lymphocytic leukemia (CLL) confer and unfavorable prognosis, induce a distinctive transcriptional profiling and refine the intermediate prognosis of +12 CLL. Haematologica. 2012, 97: 437-441.","journal-title":"Haematologica"},{"key":"3908_CR28","doi-asserted-by":"publisher","first-page":"4300","DOI":"10.1182\/blood-2008-11-187708","volume":"113","author":"P Secchiero","year":"2009","unstructured":"Secchiero P, Melloni E, di Iasio MG, Tiribelli M, Rimondi E, Corallini F, Gattei V, Zauli G: Nutlin-3 up-regulates the expression of Notch1 in both myeloid and lymphoid leukemic cells, as part of negative feedback antiapoptotic mechanism. Blood. 2009, 113: 4300-4308.","journal-title":"Blood"},{"key":"3908_CR29","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1038\/nrc2675","volume":"9","author":"G Paolo Dotto","year":"2009","unstructured":"Paolo Dotto G: Crosstalk of Notch with p53 and p63 in cancer growth control. Nature Rev. Cancer. 2009, 9: 587-595.","journal-title":"Nature Rev. Cancer"},{"key":"3908_CR30","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1111\/j.1365-2141.2012.09155.x","volume":"158","author":"D Rossi","year":"2012","unstructured":"Rossi D, Rasi S, Spina V, Fangazio M, Monti S, Greco M, Ciardullo C, Fam\u00e0 R, Cresta S, Bruscaggin A, Laurenti L, Martini M, Musto P, Forconi F, Marasca R, Larocca LM, Fo\u00e0 R, Gaidano G: Different impact of NOTCH1 and SF3B1 mutations on the risk of chronic lymphocytic leukemia transformation to Richter syndrome. British Journal of Haematoloy. 2012, 158: 426-229.","journal-title":"British Journal of Haematoloy"},{"key":"3908_CR31","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1038\/leu.2012.25","volume":"26","author":"S Pospisilova","year":"2012","unstructured":"Pospisilova S, Gonzalez D, Malcikova J, Trbusek M, Rossi D, Kater AP, Cymbalista F, Eichhorst B, Hallek M, D\u00f6hner H, Hillmen P, van Oers M, Gribben J, Ghia P, Montserrat E, Stilgenbauer S, Zenz T: ERIC recommendations on TP53 mutation analysis in chronic lymphocytic leukemia. Leukemia. 2012, 26: 1458-1461.","journal-title":"Leukemia"},{"key":"3908_CR32","doi-asserted-by":"publisher","first-page":"4101","DOI":"10.1182\/blood-2011-11-312421","volume":"119","author":"T Zenz","year":"2012","unstructured":"Zenz T, Gribben JG, Hallek M, D\u00f6hner H, Keating MJ, Stielgenbauer S: Risk categories and refractory CLL in era of chemoimmunotherapy. Blood. 2012, 119: 4101-4107.","journal-title":"Blood"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-13-274.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2407-13-274\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-13-274","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,27]],"date-time":"2020-07-27T17:55:34Z","timestamp":1595872534000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/1471-2407-13-274"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6,4]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["3908"],"URL":"https:\/\/doi.org\/10.1186\/1471-2407-13-274","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,6,4]]},"article-number":"274"}}